Praxis Precision Medicines Q3 Results Scheduled for Nov. 9
Praxis Precision Medicines is scheduled to report Q3 results before the market opens on Nov. 9. Revenue is estimated at 0 USD, with EPS anticipated at (3.54) USD.
PRAX (Praxis Precision Medicines, Inc.) is set to announce its Q3'26 results on November 09, before the market opens. The earnings are expected to be disclosed at 9:30 AM ET (2:30 PM UTC).For Q3'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (3.54) USD. Learn more detail…